Pilot-Trans Network Core
- Institution
- Wistar Institute, PA
- Principal investigator
- Meenhard F Herlyn
- Funding
- $184K
- Duration
- 2017–2028
Moonbase score
Still being scored
Abstract
Project Summary - Pilot Projects and Trans-Network Activities Core D The overall goals of the Pilot Core are to advance high-quality research, foster new ideas for the PDX Development and Trial Center and the PDXNet in order to strengthen the foundation of ongoing studies in the projects, and to interact with investigators inside and outside of the PDTC. To accomplish these goals, two specific aims are proposed: Aim 1: To attract, select, and fund the most outstanding proposals with significant potential to benefit the PDTC and the PDXNet. Aim 2: To support and integrate the selected pilot projects into the PDTC program with established processes to review and monitor progress. Women and underrepresented minorities will be strongly encouraged to participate. The Pilot Core has a transparent peer-reviewed selection process that incorporates defined criteria for funding decisions. We will require that Pilot Project awardees be active in PDTC functions, use the PDTC and core resources, and provide formal written progress reports. Within the context of the core, we have established high standards and expectations of the investigators and have established a formal process to review and monitor progress of funded pilot projects. The program measures success by resulting publications, resulting funding, stimulating new aims in existing PDTC projects, and strengthening the resources, technologies, and approaches within the PDTC and PDXNet.
LOADING MOONBASE SCORE
Questions for Wistar Institute
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Wistar InstituteNot yet scored
SPORE in Skin Cancer
Ravi K Amaravadi · $2.4M · 2021–2026
- NIH · Wistar InstituteNot yet scored
Administrative Core
Meenhard F Herlyn · $208K · 2021–2026
- NIH · Wistar InstituteNot yet scored
Neoadjuvant immunotherapy approaches to early stage melanoma
Meenhard F Herlyn · $474K · 2021–2026